Uncategorized
Vistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage study
Vistagen’s repeat-dose anxiety nasal spray can’t beat placebo in mid-stage study
Uncategorized
Replimune to ride wave of physician support to launch advanced melanoma therapy
Analysts expect Replimune’s newly approved Tudriqev to reach $1.3 billion in peak sales in 2035.
Uncategorized
‘Significant’ demand for Revolution drug; Intellia pinpoints liver toxicity culprit

Early indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, Intellia believes it’s answered a key safety question and Arrowhead moved to catch a rival.

Early indicators from a compassionate use plan led analysts to hike projections for daraxonrasib. Elsewhere, Intellia believes it’s answered a key safety question and Arrowhead moved to catch a rival.
Uncategorized
2026 Q2 Job Market Report: Job postings keep rising as fewer companies cut employees
Job postings increase and competition dips, according to BioSpace data.
-
Fierce Biotech4 months ago
Scientists turn pig semen extract into eye drops that kill cancer in mice
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Endpoints News5 months ago
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
-
Uncategorized5 months agoNovartis buys Synnovation’s PI3Kα inhibitors for $3 billion
-
Uncategorized9 years agoAccording to Dior Couture, this taboo fashion accessory is back
-
Uncategorized9 years agoSteph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years agoPhillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years agoUber and Lyft are finally available in all of New York State